 |
cinacalcet |
|---|---|
| Trade Name | Sensipar |
| Orphan Indication | Hypercalcemia in patients with primary hyperparathyroidism for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo surgery |
| USA Market Approval | USA |
| USA Designation Date | 2010-04-30 00:00:00 |
| Sponsor | Amgen, Inc.;One Amgen Center Drive, Bldg 17, 1A-4-4, Mail Stop 17-1-B;Thousand Oaks, California, 91320 |
